Image

Advanced Lung and Colorectal Cancer Are the Two Leading Causes of Cancer-Related Deaths Globally

Image
Image

Lumeda Is Introducing New Therapy to Address These Challenges

 

Image

The company was formed to commercialize novel medical device technology that expands the use of photodynamic therapy (PDT) into new sites and indications. PDT is a proven therapy that is safe and free of systemic toxicities to offer an effective therapeutic option for an improved patient and provider experience. Our breakthrough therapy overcomes the barriers of legacy PDT for broad adoption. Our initial indications address major treatment gaps in the standard of care for patients with advanced lung and colorectal cancer which account for over 70% of global cancer related deaths. This also has the potential to reduce health disparities of underserved or underrepresented communities who are disproportionally diagnosed with lung and colorectal cancers at an advanced stage.

   Learn More

 

New Breakthrough in Photodynamic Therapy

Image
Image

New Hope for Patients with Advanced Lung and Colorectal Cancer

A Clinical Stage Company

   Learn More

 

Image
Image

Large Market Opportunity